{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:19:24Z","timestamp":1789755564579,"version":"4.0.1"},"reference-count":95,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1097\/wad.0000000000000076","type":"journal-article","created":{"date-parts":[[2014,12,31]],"date-time":"2014-12-31T16:23:25Z","timestamp":1420043005000},"page":"1-5","source":"Crossref","is-referenced-by-count":35,"title":["Dantrolene, A Treatment for Alzheimer Disease?"],"prefix":"10.1097","volume":"29","author":[{"given":"Li","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huafeng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210128","doi-asserted-by":"crossref","first-page":"254954","DOI":"10.1155\/2013\/254954","article-title":"Genetics of Alzheimers disease.","volume":"2013","author":"Ridge","year":"2013","journal-title":"Biomed Res Int"},{"key":"R2-1-20210128","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/nrneurol.2014.44","article-title":"Alzheimer disease: lessons from immunotherapy for Alzheimer disease.","volume":"10","author":"Wang","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"R3-1-20210128","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.bcp.2013.12.024","article-title":"Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers.","volume":"88","author":"Reitz","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"R5-1-20210128","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nrneurol.2014.25","article-title":"Alzheimer disease: high serum levels of the pesticide metabolite DDEa potential environmental risk factor for Alzheimer disease.","volume":"10","author":"Bible","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"R6-1-20210128","doi-asserted-by":"crossref","first-page":"e99171","DOI":"10.1371\/journal.pone.0099171","article-title":". Comparison of neurodegeneration and cognitive impairment in neonatal mice exposed to propofol or isoflurane.","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS One"},{"key":"R7-1-20210128","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/ALN.0000000000000316","article-title":". General anesthetic isoflurane modulates inositol 1, 4, 5-trisphosphate receptor calcium channel opening.","volume":"121","author":"Joseph","year":"2014","journal-title":"Anesthesiology"},{"key":"R8-1-20210128","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1111\/ejn.12527","article-title":"Beta-amyloid pathology alters neural network activation during retrieval of contextual fear memories in a mouse model of Alzheimers disease.","volume":"39","author":"Lelos","year":"2014","journal-title":"Eur J Neurosci"},{"key":"R9-1-20210128","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000353686","article-title":". Beta-amyloid precursor protein: function in stem cell development and Alzheimers disease brain.","volume":"13","author":"Small","year":"2014","journal-title":"Neurodegener Dis"},{"key":"R10-1-20210128","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.jagp.2013.06.005","article-title":". Neurobiology of delusions, memory, and insight in Alzheimer disease.","volume":"22","author":"Sultzer","year":"2013","journal-title":"Am J Geriatr Psychiatry"},{"key":"R11-1-20210128","first-page":"445","article-title":"A Toll road to Alzheimer diseaseCNS Neurol Disord Drug Targets.","volume":"12","author":"Skaper","year":"2013","journal-title":""},{"key":"R12-1-20210128","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jamda.2013.01.014","article-title":"The role of nutrition and diet in Alzheimer disease: a systematic review.","volume":"14","author":"Shah","year":"2013","journal-title":"J Am Med Dir Assoc"},{"key":"R13-1-20210128","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1017\/S1461145705005833","article-title":"Targeting acetylcholinesterase and butyrylcholinesterase in dementia.","volume":"9","author":"Lane","year":"2006","journal-title":"Int J Neuropsychopharmacol"},{"key":"R14-1-20210128","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2174\/156802606776743066","article-title":". The role of amyloid-beta derived diffusible ligands (ADDLs) in Alzheimers disease.","volume":"6","author":"Catalano","year":"2006","journal-title":"Curr Top Med Chem"},{"key":"R15-1-20210128","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.biocel.2008.12.015","article-title":"Reassessing the amyloid cascade hypothesis of Alzheimers disease.","volume":"41","author":"Pimplikar","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"key":"R16-1-20210128","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3233\/JAD-131061","article-title":". Amyloid-beta alters the DNA methylation status of cell-fate genes in an Alzheimers disease model.","volume":"38","author":"Taher","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"R17-1-20210128","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3233\/JAD-2012-120508","article-title":". Amyloid-beta(1-1516) as a marker for gamma-secretase inhibition in Alzheimers disease.","volume":"31","author":"Portelius","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"R18-1-20210128","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimers disease: progress and problems on the road to therapeutics.","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"R20-1-20210128","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.1021\/ja100943r","article-title":"A prochelator activated by beta-secretase inhibits Abeta aggregation and suppresses copper-induced reactive oxygen species formation.","volume":"132","author":"Folk","year":"2010","journal-title":"J Am Chem Soc"},{"key":"R21-1-20210128","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00401-010-0719-5","article-title":". Neuropathology after active Abeta42 immunotherapy: implications for Alzheimers disease pathogenesis.","volume":"120","author":"Boche","year":"2010","journal-title":"Acta Neuropathol"},{"key":"R22-1-20210128","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nrneurol.2013.223","article-title":"Alzheimer disease therapymoving from amyloid-beta to tau.","volume":"9","author":"Giacobini","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"R23-1-20210128","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jalz.2013.11.003","article-title":"The amyloid hypothesis, time to move on: amyloid is the downstream result, not cause, of Alzheimers disease.","volume":"10","author":"Drachman","year":"2014","journal-title":"Alzheimers Dement"},{"key":"R24-1-20210128","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.bcp.2014.01.002","article-title":"Alzheimer disease therapeutics: focus on the disease and not just plaques and tangles.","volume":"88","author":"Iqbal","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"R25-1-20210128","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1586\/1744666X.2014.883921","article-title":". Amyloid-based immunotherapy for Alzheimers disease in the time of prevention trials: the way forward.","volume":"10","author":"Panza","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"key":"R26-1-20210128","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nrd3505","article-title":"The amyloid cascade hypothesis for Alzheimers disease: an appraisal for the development of therapeutics.","volume":"10","author":"Karran","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"R27-1-20210128","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.neurobiolaging.2013.10.085","article-title":"Why Alzheimer trials fail: removing soluble oligomeric beta amyloid is essential, inconsistent, and difficult.","volume":"35","author":"Rosenblum","year":"2014","journal-title":"Neurobiol Aging"},{"key":"R28-1-20210128","first-page":"128","article-title":"Imbimbo BP, et al..","volume":"27","author":"Panza","year":"2014","journal-title":"Is there still any hope for amyloid-based immunotherapy for Alzheimers diseaseCurr Opin Psychiatry"},{"key":"R29-1-20210128","first-page":"367","article-title":"The missing link in the amyloid cascade of Alzheimers diseasemetal ionsNeurochem Int.","volume":"62","author":"Tiiman","year":"2013","journal-title":""},{"key":"R30-1-20210128","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.bbadis.2013.09.010","article-title":"The Alzheimers disease mitochondrial cascade hypothesis: progress and perspectives.","volume":"1842","author":"Swerdlow","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"R31-1-20210128","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00401-013-1177-7","article-title":"The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy.","volume":"126","author":"McGeer","year":"2013","journal-title":"Acta Neuropathol"},{"key":"R32-1-20210128","first-page":"194","article-title":"Role of Ca2 and other second messengers in excitatory amino acid receptor mediated neurodegeneration: clinical perspectives.","volume":"4","author":"Schousboe","year":"1997","journal-title":"Clin Neurosci"},{"key":"R33-1-20210128","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00424-009-0736-1","article-title":"Calcium hypothesis of Alzheimers disease.","volume":"459","author":"Berridge","year":"2010","journal-title":"Pflugers Arch"},{"key":"R34-1-20210128","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ceca.2014.02.005","article-title":"Calcium dysregulation, and lithium treatment to forestall Alzheimers diseasea merging of hypotheses.","volume":"55","author":"Wallace","year":"2014","journal-title":"Cell Calcium"},{"key":"R35-1-20210128","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1515\/revneuro-2013-0056","article-title":"Why calcium channel blockers could be an elite choice in the treatment of Alzheimers disease: a comprehensive review of evidences.","volume":"25","author":"Saravanaraman","year":"2014","journal-title":"Rev Neurosci"},{"issue":"pt 2","key":"R36-1-20210128","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1113\/jphysiol.2013.257527","article-title":"Calcium regulation of neural rhythms, memory and Alzheimers disease.","volume":"592","author":"Berridge","year":"2014","journal-title":"J Physiol"},{"key":"R37-1-20210128","doi-asserted-by":"crossref","first-page":"26955","DOI":"10.1074\/jbc.M113.473355","article-title":". Ca2 influx through store-operated Ca2 channels reduces Alzheimer disease beta-amyloid peptide secretion.","volume":"288","author":"Zeiger","year":"2013","journal-title":"J Biol Chem"},{"key":"R38-1-20210128","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fnmol.2013.00029","article-title":"Role of endoplasmic reticulum Ca2 signaling in the pathogenesis of Alzheimer disease.","volume":"6","author":"Popugaeva","year":"2013","journal-title":"Front Mol Neurosci"},{"key":"R39-1-20210128","first-page":"59","article-title":"Calcium hypothesis of Alzheimer disease.","volume":"43","author":"Riazantseva","year":"2012","journal-title":"Usp Fiziol Nauk"},{"key":"R40-1-20210128","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.mcn.2012.07.011","article-title":"Mitochondria-associated ER membranes in Alzheimer disease.","volume":"55","author":"Schon","year":"2013","journal-title":"Mol Cell Neurosci"},{"key":"R41-1-20210128","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.neurobiolaging.2009.03.003","article-title":". Cyclophilin D deficiency improves mitochondrial function and learningmemory in aging Alzheimer disease mouse model.","volume":"32","author":"Du","year":"2011","journal-title":"Neurobiol Aging"},{"key":"R42-1-20210128","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.bbadis.2011.08.013","article-title":"Calcium channel blocking as a therapeutic strategy for Alzheimers disease: the case for isradipine.","volume":"1812","author":"Anekonda","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"R43-1-20210128","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1073\/pnas.0813355106","article-title":". Small molecule blockers of the Alzheimer Abeta calcium channel potently protect neurons from Abeta cytotoxicity.","volume":"106","author":"Diaz","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R44-1-20210128","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neurobiolaging.2004.03.009","article-title":". Calcium channel blockers and risk of AD: the Baltimore Longitudinal Study of Aging.","volume":"26","author":"Yasar","year":"2005","journal-title":"Neurobiol Aging"},{"key":"R45-1-20210128","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ceca.2009.12.014","article-title":"The dysregulation of intracellular calcium in Alzheimer disease.","volume":"47","author":"Supnet","year":"2010","journal-title":"Cell Calcium"},{"key":"R46-1-20210128","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/ajmg.b.30896","article-title":". Evidence supporting a role for the calcium-sensing receptor in Alzheimer disease.","volume":"150B","author":"Conley","year":"2009","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"R47-1-20210128","first-page":"139","article-title":"Can the calcium hypothesis explain synaptic loss in Alzheimers diseaseNeurodegener Dis.","volume":"13","author":"Popugaeva","year":"2014","journal-title":""},{"key":"R48-1-20210128","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ceca.2011.05.013","article-title":"Presenilins function in ER calcium leak and Alzheimers disease pathogenesis.","volume":"50","author":"Supnet","year":"2011","journal-title":"Cell Calcium"},{"key":"R49-1-20210128","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1750-1326-6-81","article-title":". Dantrolene is neuroprotective in Huntingtons disease transgenic mouse model.","volume":"6","author":"Chen","year":"2011","journal-title":"Mol Neurodegener"},{"key":"R50-1-20210128","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0197-4580(87)90073-X","article-title":"Hypothesis on the regulation of cytosol calcium concentration and the aging brain.","volume":"8","author":"Khachaturian","year":"1987","journal-title":"Neurobiol Aging"},{"key":"R51-1-20210128","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s11427-011-4201-y","article-title":"Presenilins as endoplasmic reticulum calcium leak channels and Alzheimers disease pathogenesis.","volume":"54","author":"Supnet","year":"2011","journal-title":"Sci China Life Sci"},{"key":"R52-1-20210128","doi-asserted-by":"crossref","first-page":"72","DOI":"10.32607\/20758251-2010-2-1-72-80","article-title":"Calcium signaling and neurodegeneration.","volume":"2","author":"Bezprozvanny","year":"2010","journal-title":"Acta Naturae"},{"key":"R53-1-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/REVNEURO.2009.20.1.1","article-title":"Is Alzheimers disease a result of presynaptic failure Synaptic dysfunctions induced by oligomeric beta-amyloid.","volume":"20","author":"Nimmrich","year":"2009","journal-title":"Rev Neurosci"},{"key":"R54-1-20210128","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1600-079X.2011.00937.x","article-title":". Alzheimers disease: pathological mechanisms and the beneficial role of melatonin.","volume":"52","author":"Rosales-Corral","year":"2012","journal-title":"J Pineal Res"},{"key":"R55-1-20210128","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1021\/cn3001069","article-title":". Stabilizers of neuronal and mitochondrial calcium cycling as a strategy for developing a medicine for Alzheimers disease.","volume":"3","author":"Fernandez-Morales","year":"2012","journal-title":"ACS Chem Neurosci"},{"key":"R56-1-20210128","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s11064-010-0371-4","article-title":"Calcium signalling and Alzheimers disease.","volume":"36","author":"Berridge","year":"2011","journal-title":"Neurochem Res"},{"key":"R57-1-20210128","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0166-2236(97)01156-9","article-title":"Calcium and neuronal ageing.","volume":"21","author":"Verkhratsky","year":"1998","journal-title":"Trends Neurosci"},{"key":"R58-1-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1471-4159.1998.70010001.x","article-title":". Presenilins, the endoplasmic reticulum, and neuronal apoptosis in Alzheimers disease.","volume":"70","author":"Mattson","year":"1998","journal-title":"J Neurochem"},{"key":"R59-1-20210128","first-page":"78","article-title":"Calcium and the aging brain: upsetting a delicate balanceGeriatrics.","volume":"46","author":"Khachaturian","year":"1991","journal-title":""},{"key":"R60-1-20210128","first-page":"120","article-title":"Apoptosis in neurodegenerative disorders. Nature reviews.","volume":"1","author":"Mattson","year":"2000","journal-title":"Mol Cell Biol"},{"key":"R61-1-20210128","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1189\/jlb.70.4.677","article-title":". Apolipoprotein E and mimetic peptide initiate a calcium-dependent signaling response in macrophages.","volume":"70","author":"Misra","year":"2001","journal-title":"J Leukoc Biol"},{"key":"R62-1-20210128","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/13550280290100978","article-title":"Oxidative stress, perturbed calcium homeostasis, and immune dysfunction in Alzheimers disease.","volume":"8","author":"Mattson","year":"2002","journal-title":"J Neurovirol"},{"key":"R63-1-20210128","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1515\/rns.2011.029","article-title":"Synapses, NMDA receptor activity and neuronal Abeta production in Alzheimers disease.","volume":"22","author":"Bordji","year":"2011","journal-title":"Rev Neurosci"},{"key":"R64-1-20210128","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.tips.2005.12.008","article-title":"The role of the endoplasmic reticulum Ca2 store in the plasticity of central neurons.","volume":"27","author":"Bardo","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"R65-1-20210128","doi-asserted-by":"crossref","first-page":"12128","DOI":"10.1523\/JNEUROSCI.2474-10.2010","article-title":"NMDA-mediated Ca(2) influx drives aberrant ryanodine receptor activation in dendrites of young Alzheimers disease mice.","volume":"30","author":"Goussakov","year":"2010","journal-title":"J Neurosci"},{"key":"R66-1-20210128","doi-asserted-by":"crossref","first-page":"12463","DOI":"10.1074\/jbc.R109.080895","article-title":"Calcium signaling and amyloid toxicity in Alzheimer disease.","volume":"285","author":"Demuro","year":"2010","journal-title":"J Biol Chem"},{"key":"R67-1-20210128","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fnmol.2013.00036","article-title":". Alzheimers disease-associated peptide Abeta42 mobilizes ER Ca(2) via InsP3R-dependent and -independent mechanisms.","volume":"6","author":"Jensen","year":"2013","journal-title":"Front Mol Neurosci"},{"key":"R68-1-20210128","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1742-2094-6-41","article-title":". ER stress in Alzheimers disease: a novel neuronal trigger for inflammation and Alzheimers pathology.","volume":"6","author":"Salminen","year":"2009","journal-title":"J Neuroinflammation"},{"key":"R69-1-20210128","doi-asserted-by":"crossref","first-page":"6691","DOI":"10.1111\/febs.12572","article-title":". Trichostatin A epigenetically increases calpastatin expression and inhibits calpain activity and calcium-induced SH-SY5Y neuronal cell toxicity.","volume":"280","author":"Seo","year":"2013","journal-title":"FEBS J"},{"key":"R70-1-20210128","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3233\/JAD-130560","article-title":". CaV1.2 calcium channel expression in reactive astrocytes is associated with the formation of amyloid-beta plaques in an Alzheimers disease mouse model.","volume":"37","author":"Daschil","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"R71-1-20210128","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejphar.2013.11.012","article-title":"Calcium channelopathies and Alzheimers disease: Insight into therapeutic success and failures.","volume":"739","author":"Chakroborty","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"R72-1-20210128","doi-asserted-by":"crossref","first-page":"8341","DOI":"10.1523\/JNEUROSCI.0936-12.2012","article-title":". Early presynaptic and postsynaptic calcium signaling abnormalities mask underlying synaptic depression in presymptomatic Alzheimers disease mice.","volume":"32","author":"Chakroborty","year":"2012","journal-title":"J Neurosci"},{"key":"R73-1-20210128","doi-asserted-by":"crossref","first-page":"5180","DOI":"10.1523\/JNEUROSCI.0739-06.2006","article-title":". Enhanced ryanodine receptor recruitment contributes to Ca2 disruptions in young, adult, and aged Alzheimers disease mice.","volume":"26","author":"Stutzmann","year":"2006","journal-title":"J Neurosci"},{"key":"R74-1-20210128","first-page":"110","article-title":"Calcium dysregulation, IP3 signaling, and Alzheimers diseaseNeuroscientist.","volume":"11","author":"Stutzmann","year":"2005","journal-title":""},{"key":"R75-1-20210128","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4142\/jvs.2001.2.2.131","article-title":"Effect of IP3 and ryanodine treatments on the development of bovine parthenogenetic and reconstructed embryos.","volume":"2","author":"Ahn","year":"2001","journal-title":"J Vet Sci"},{"key":"R76-1-20210128","first-page":"180741","article-title":". Spectral analysis of EEG in familial Alzheimers disease with E280A presenilin-1 mutation gene.","volume":"2014","author":"Rodriguez","year":"2014","journal-title":"Int J Alzheimers Dis"},{"key":"R77-1-20210128","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3233\/JAD-130746","article-title":"Presenilin-1 mutations in Alzheimers disease: an update on genotype-phenotype relationships.","volume":"37","author":"Larner","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"R78-1-20210128","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/978-94-007-2888-2_9","article-title":"Ryanodine receptor physiology and its role in disease.","volume":"740","author":"Lanner","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"R80-1-20210128","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1196\/annals.1379.025","article-title":". Enhanced ryanodine-mediated calcium release in mutant PS1-expressing Alzheimers mouse models.","volume":"1097","author":"Stutzmann","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"R81-1-20210128","doi-asserted-by":"crossref","first-page":"9458","DOI":"10.1523\/JNEUROSCI.2047-09.2009","article-title":". Deviant ryanodine receptor-mediated calcium release resets synaptic homeostasis in presymptomatic 3xTg-AD mice.","volume":"29","author":"Chakroborty","year":"2009","journal-title":"J Neurosci"},{"key":"R82-1-20210128","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ceca.2008.03.004","article-title":". The N-terminus of presenilin-2 increases single channel activity of brain ryanodine receptors through direct protein-protein interaction.","volume":"44","author":"Hayrapetyan","year":"2008","journal-title":"Cell Calcium"},{"key":"R83-1-20210128","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1161\/CIRCRESAHA.114.303391","article-title":". Divergent regulation of ryanodine receptor 2 calcium release channels by arrhythmogenic human calmodulin missense mutants.","volume":"114","author":"Hwang","year":"2014","journal-title":"Circ Res"},{"key":"R84-1-20210128","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00439-013-1354-8","article-title":"Genetic interactions found between calcium channel genes modulate amyloid load measured by positron emission tomography.","volume":"133","author":"Koran","year":"2014","journal-title":"Hum Genet"},{"key":"R85-1-20210128","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.biocel.2012.07.019","article-title":"Presenilins: role in calcium homeostasis.","volume":"44","author":"Honarnejad","year":"2012","journal-title":"Int J Biochem Cell Biol"},{"key":"R86-1-20210128","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.tiv.2012.06.019","article-title":". Lead-induced ER calcium release and inhibitory effects of methionine choline in cultured rat hippocampal neurons.","volume":"27","author":"Fan","year":"2013","journal-title":"Toxicol In Vitro"},{"key":"R87-1-20210128","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4161\/chan.5.1.14124","article-title":"Generation of dendritic Ca2 oscillations as a consequence of altered ryanodine receptor function in AD neurons.","volume":"5","author":"Goussakov","year":"2011","journal-title":"Channels"},{"key":"R88-1-20210128","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/jce.12320","article-title":". Dantrolene suppresses ventricular ectopy and arrhythmogenicity with acute myocardial infarction in a langendorff-perfused pacing-induced heart failure rabbit model.","volume":"25","author":"Chou","year":"2014","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R89-1-20210128","doi-asserted-by":"crossref","first-page":"390493","DOI":"10.1155\/2013\/390493","article-title":"Dantrolene-induced inhibition of skeletal L-type Ca2 current requires RyR1 expression.","volume":"2013","author":"Bannister","year":"2013","journal-title":"Biomed Res Int"},{"key":"R90-1-20210128","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neuroscience.2012.06.050","article-title":". Dantrolene is neuroprotective in vitro, but does not affect survival in SOD1(G(9)(3)A) mice.","volume":"220","author":"Staats","year":"2012","journal-title":"Neuroscience"},{"key":"R91-1-20210128","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/EJA.0b013e32834c7c9d","article-title":". Dantrolene for severe rhabdomyolysis in Staphylococcus aureus toxic shock syndrome.","volume":"29","author":"Ginz","year":"2012","journal-title":"Eur J Anaesthesiol"},{"key":"R92-1-20210128","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0197-0186(03)00012-3","article-title":"Dantrolene inhibits NMDA-induced 45Ca uptake in cultured cerebellar granule neurons.","volume":"43","author":"Makarewicz","year":"2003","journal-title":"Neurochem Int"},{"key":"R93-1-20210128","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1523\/JNEUROSCI.20-04-01358.2000","article-title":". Presenilin-1 mutation increases neuronal vulnerability to focal ischemia in vivo and to hypoxia and glucose deprivation in cell culture: involvement of perturbed calcium homeostasis.","volume":"20","author":"Mattson","year":"2000","journal-title":"J Neurosci"},{"key":"R94-1-20210128","doi-asserted-by":"crossref","first-page":"9148","DOI":"10.1523\/JNEUROSCI.0660-09.2009","article-title":". Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 2.","volume":"29","author":"Liu","year":"2009","journal-title":"J Neurosci"},{"key":"R95-1-20210128","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.neulet.2012.04.008","article-title":". Dantrolene ameliorates cognitive decline and neuropathology in Alzheimer triple transgenic mice.","volume":"516","author":"Peng","year":"2012","journal-title":"Neurosci Lett"},{"key":"R96-1-20210128","doi-asserted-by":"crossref","first-page":"11820","DOI":"10.1523\/JNEUROSCI.0875-12.2012","article-title":". Ryanodine receptor blockade reduces amyloid-beta load and memory impairments in Tg2576 mouse model of Alzheimer disease.","volume":"32","author":"Oules","year":"2014","journal-title":"J Neurosci"},{"key":"R97-1-20210128","doi-asserted-by":"crossref","first-page":"e52056","DOI":"10.1371\/journal.pone.0052056","article-title":". Stabilizing ER Ca2 channel function as an early preventative strategy for Alzheimers disease.","volume":"7","author":"Chakroborty","year":"2012","journal-title":"PLoS One"},{"key":"R98-1-20210128","doi-asserted-by":"crossref","first-page":"8566","DOI":"10.1523\/JNEUROSCI.1554-10.2010","article-title":". Role of presenilins in neuronal calcium homeostasis.","volume":"30","author":"Zhang","year":"2010","journal-title":"J Neurosci"}],"container-title":["Alzheimer Disease & Associated Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WAD.0000000000000076","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T08:01:25Z","timestamp":1690790485000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002093-201501000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/wad.0000000000000076","relation":{},"ISSN":["0893-0341"],"issn-type":[{"value":"0893-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]}}}